• Contact
  • Privacy Policy
  • Advertise With Us
  • Login
  • Register
Your Trading Edge Magazine
Advertisement
  • Home
  • Feature
    • Market Commentary
    • Expert Advice
    • Columns
  • Trading
    • Shares and Trading
    • Technical Analysis
    • Trading Mindset
  • Crypto News
  • Finance
  • Subscribe
No Result
View All Result
  • Home
  • Feature
    • Market Commentary
    • Expert Advice
    • Columns
  • Trading
    • Shares and Trading
    • Technical Analysis
    • Trading Mindset
  • Crypto News
  • Finance
  • Subscribe
No Result
View All Result
Your Trading Edge Magazine
No Result
View All Result

COVID-19 Update: Dynavax Increases by 26%

September 23, 2021
in Trading
Reading Time: 3 mins read
A A
0
COVID-19 Update: Dynavax Increases by 26%
0
SHARES
14
VIEWS
ShareShareShareShareShare

Dynavax Technologies reports pivotal trial results that boosted its share price by 26%. The company developed an adjuvant to make a COVID-19 vaccine more effective.  

We are nowhere near the end of the pandemic. Yet, the good news is that many companies continue their R&D research on potential COVID-19 vaccines. Yesterday, Dynavax and its collaboration partner released positive trial results that used a booster to make the vaccine more effective.

Let’s find out more about Dynavax and why this news made investors push its stock 26.6% higher yesterday and over 30% in the past five days.

How & Where to Buy Dynavax Technologies Stock Online

Dynavax Technologies (NASDAQ: DVAX) and its collaboration partner, Clover Biopharmaceuticals, can be bought via online brokers. If you want to invest in these stocks, all you need to do is to choose a brokerage platform that provides access to Nasdaq stocks and create an account. Our top picks are:

eToro

eToro is one of the world’s leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It’s social copy trading features make it a great choice for those getting started.

Register with eToro instantly

Pepperstone

Pepperstone was founded in 2010 in Melbourne, Australia by a team of experienced traders with a shared commitment to improve the world of online trading. Frustrated by delayed executions, expensive prices and poor customer support, they set out to provide traders around the world with superior technology, low-cost spreads and a genuine commitment to helping them master the trade. Their mission is to create a world of tech-enabled trading where ambitious traders can embrace the challenge and opportunity of global markets.

Register with Pepperstone instantly

What Is Dynavax Technologies?

Dynavax Technologies specialises in developing vaccines by using innovative technologies. One example is the HEPLISAV-B, a vaccine for Hepatitis B, which is also the main revenue source for the company.

Should I Buy Dynavax Technologies Today?

Dynavax Technologies partnered with Clover Biopharmaceuticals to develop a more effective COVID-19 vaccine. Yesterday, DVAX reported that their protein-based vaccine candidate, known as SCB-2019, was proved effective following a clinical trial that included more than 30,000 participants. The new vaccine has 100% efficacy against severe COVID-19 cases and 84% efficacy against moderate-to-severe cases caused by any strain.

Given the increasing concerns over the new variants, including Delta, investors embraced the news with optimism. The share price surged following this news; yet, it may be a long way until the vaccine is ready for administration at a global level. 

Dynavax Technologies Price Prediction 2021

Currently trading at $18.79, analysts expect the stock to reach a high target price of $23 in the next 12 months. The bearish scenario shows a minimum of $18.

Credit: Source link

ShareTweetSendPinShare
Previous Post

‘We don’t want to play the blame game,’ says Benton Harbor mayor

Next Post

Nike stock price declining ahead of the quarterly earnings

Related Posts

5 Ways to Save Money While Scaling Your Logistics
Trading

U.S. Small Business Administration Announces Small Business Investment Companies of the Year

April 1, 2023
3
Baker Hughes US oil rig counts see the first quarterly decline since 2020Q3
Trading

Baker Hughes US oil rig counts see the first quarterly decline since 2020Q3

April 1, 2023
4
Nikola shares down 15% on secondary stock offering: buy the dip?
Trading

Nikola shares down 15% on secondary stock offering: buy the dip?

April 1, 2023
2
Biotech stock Pacific Biosciences could return 50% in 12 month TD Cowen
Trading

Biotech stock Pacific Biosciences could return 50% in 12 month TD Cowen

April 1, 2023
9
US housing data signals an improvement in lumber demand
Trading

US housing data signals an improvement in lumber demand

April 1, 2023
5
Next Post
Nike stock price declining ahead of the quarterly earnings

Nike stock price declining ahead of the quarterly earnings

Recommended

Propane Now Reducing Emissions Through Recharging…

Propane Now Reducing Emissions Through Recharging…

March 4, 2023
5
Signature bank Board member and former congressman openly admits that bank was arbitrary shuttered to send an anti-crypto message

Signature bank Board member and former congressman openly admits that bank was arbitrary shuttered to send an anti-crypto message

March 15, 2023
7
Congressman Emmer attacks FDIC for ‘weaponizing’ bank closures to attack crypto

Congressman Emmer attacks FDIC for ‘weaponizing’ bank closures to attack crypto

March 16, 2023
7
Silicon Valley Bank in Talks to Sell Itself After Failed Capital Raise: Report

USDC Tumbles to $0.93 as Circle Reveals $3.3 Billion Held at SVB, Tether and Binance Not Exposed

March 11, 2023
5
Focus shifts to March 14

Focus shifts to March 14

March 8, 2023
4
Your Trading Edge Magazine

This is an online news portal that aims to share the latest news about trade, finance, crypto and much more. Feel free to get in touch with us!

What’s New Here!

  • Bitcoin (BTC) and Ethereum (ETH) options gain popularity among investors as open interest skyrockets
  • Bitcoin Leads the Way by Outperforming Most Assets in Q1: Report
  • Bittrex To Suspend U.S. Operations Due to Regulatory Issues

Subscribe Now

Loading
  • Contact
  • Privacy Policy
  • Advertise With Us

© 2021 - ytemagazine.com - All rights reserved!

No Result
View All Result
  • Home
  • Feature
    • Market Commentary
    • Expert Advice
    • Columns
  • Trading
    • Shares and Trading
    • Technical Analysis
    • Trading Mindset
  • Crypto News
  • Finance
  • Subscribe

© 2021 - ytemagazine.com - All rights reserved!

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?